The alveo lung simulator from IMT Analytics replicates realistic human lung behavior to assist medical device manufacturers, clinicians, and researchers in respiratory care.
RT’s Three Key Takeaways:
- Advanced Physiological Modeling: The simulator uses a precision turbine-driven system to replicate realistic lung compliance, resistance, and specific disease states.
- Broad Industry Application: The device is designed to support medical device development, clinical training for healthcare professionals, and complex scenarios for research facilities.
- Universal Device Compatibility: The system connects to all mechanical ventilation, anesthesia devices, and resuscitation bags to provide versatile training sessions across different platforms.
IMT Analytics AG has launched alveo, a high-fidelity lung simulator designed for medical device manufacturers, simulation centers, healthcare professionals, and research institutions.
The device utilizes physiological modeling to replicate realistic lung behavior, allowing users to simulate real-world conditions for the development, validation, and verification of respiratory technologies. For clinical teams, the simulator provides an environment to practice diagnostic skills and advanced treatment techniques.
“alveo represents a paradigm shift in how to train and innovate in lung simulation,” said Harri Friberg, owner of IMT Analytics AG. “Its ability to replicate lung function with accuracy and high fidelity opens new possibilities for training, research, and device development. This tool can potentially improve patient outcomes through improved simulation training, advance scientific knowledge, and accelerate innovation in respiratory care.”
The simulator features a precision turbine-driven system to control airflow and lung conditions in real-time, according to company specifications. It accounts for the viscoelastic properties of lung tissue to simulate stress responses, including gradual recruitment and hysteresis in pressure-volume curves.
The system includes adjustable settings for functional residual capacity from 10 to 4000 mL, spontaneous breath rates up to 100 breaths per minute, and airway resistance from 5 to 500 mbar/L/s. It supports adult, pediatric, and neonatal configurations and includes a library of patient profiles, such as acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD).
The 6.8-kg device is operated via an 11-inch tablet and offers universal compatibility with mechanical ventilation, anesthesia devices, and resuscitation bags.
Source:
- https://respiratory-therapy.com/products-treatment/diagnostics-testing/training/imt-analytics-launches-alveo-lung-simulator/
- https://imtanalytics.com/products/alveo
